Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
93.69
+2.23 (2.44%)
At close: Aug 29, 2025, 4:00 PM
94.58
+0.89 (0.95%)
After-hours: Aug 29, 2025, 7:00 PM EDT
Inspire Medical Systems Market Cap
Inspire Medical Systems has a market cap or net worth of $2.77 billion as of August 29, 2025. Its market cap has decreased by -51.16% in one year.
Market Cap
2.77B
Enterprise Value
2.50B
1-Year Change
-51.16%
Ranking
Category
Stock Price
$93.69
Market Cap Chart
Since May 3, 2018, Inspire Medical Systems's market cap has increased from $505.61M to $2.77B, an increase of 448.01%. That is a compound annual growth rate of 26.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 2.77B | -50.12% |
| Dec 31, 2024 | 5.56B | -7.51% |
| Dec 29, 2023 | 6.01B | -17.47% |
| Dec 30, 2022 | 7.28B | 15.62% |
| Dec 31, 2021 | 6.29B | 24.23% |
| Dec 31, 2020 | 5.07B | 191.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |